Telomir Pharmaceuticals, Inc.
TELO · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Whalen Matthew Pratt: Form 4
Insider disclosure · Filed · Report period 16 Apr 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- TELO · 87975F104 - Common Stock, no par value
Company details and SEC sources
CIK 0001971532 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- TELO on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 100 Se 2 Nd St, Suite 2000 #1009, Miami, FL, 33131
- Incorporated in
- FL
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields